InsiderClue
← All stocks

Tarsus Pharmaceuticals, Inc.

TARS Net selling
CIK 0001819790 #1728 in the set updated 17 Sep 2026
Bought (120 mo)
$16.53M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$65.89M
$18.07M on a plan · $167.75K straight out of an exercise
Sold at will
$47.66M
191 of 257 sales
Net
−$49.37M
−$31.13M against sales at will

By person

24 insiders · 271 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Azamian Bobak R.
President/CEO and Board Chair
—
$15.04M (88) scheduled
−$15.04M
1,709,403
3.90%
$145.30M
−19.0%
RTW INVESTMENTS, LP entity
10% owner
—
$13.49M (1)
−$13.49M
2,013,601
4.59%
$171.16M
−18.3%
Vivo Capital IX, LLC entity
10% owner
$4.00M (1)
$14.46M (10)
−$10.46M
8,701,367
19.83%
$739.62M
+39.6%
LINK WILLIAM J PHD
Director
—
$5.96M (13) scheduled
−$5.96M
1,219,087
2.78%
$103.62M
−2.2%
Frazier Life Sciences IX, L.P.
10% owner
$5.00M (1)
—
+$5.00M
1,917,157
4.37%
$162.96M
—
Whitfield Dianne C.
Chief Human Resources Officer
—
$3.36M (22) scheduled
−$3.36M
35,028
0.0798%
$2.98M
+1,675%
Horowitz Limited Partnership VIII entity
10% owner
$2.95M (2)
—
+$2.95M
1,987,105
4.53%
$168.90M
—
Mottiwala Aziz
Chief Commercial Officer
—
$2.87M (25)
−$2.87M
61,480
0.1401%
$5.23M
+8.3%
Tester Jason E.
Director
$2.75M (2)
—
+$2.75M
1,949,331
4.44%
$165.69M
—
Neervannan Seshadri
Chief Operating Officer
—
$2.54M (16)
−$2.54M
79,482
0.1811%
$6.76M
+41.9%
Farrow Jeffrey S
See Remarks
—
$2.33M (9)
−$2.33M
56,801
0.1294%
$4.83M
+8,014%
Lin Elizabeth Yeu
Chief Medical Officer
$456.31K (3)
$2.40M (12) scheduled
−$1.95M
32,043
0.0730%
$2.72M
+102.0%
Wahl Bryan
General Counsel
—
$1.67M (17)
−$1.67M
63,959
0.1457%
$5.44M
+537.0%
Greenstein Leonard M.
Chief Financial Officer
—
$708.04K (16)
−$708.04K
26,785
0.0610%
$2.28M
−61.3%
Ackermann Michael
Director
$1.35M (1)
$752.39K (16)
+$597.61K
1,308,273
2.98%
$111.20M
+12.2%
Goodrich Katherine
Director
—
$183.38K (1) scheduled
−$183.38K
2,233
0.0051%
$189.81K
—
Trevejo Jose M.
CHIEF MEDICAL OFFICER
—
$113.02K (8) scheduled
−$113.02K
2,251
0.0051%
$191.34K
+40.3%
Goldberg Andrew D.
Director
$18.96K (1)
—
+$18.96K
19,654
0.0448%
$1.67M
—
Holdbrook Mark J.
V.P., Clinical Affairs
—
$7.50K (3)
−$7.50K
3,191
0.0073%
$271.24K
+187.2%
YARNO WENDY L
Director
—
—
—
16,654
0.0380%
$1.42M
—
CHAUDHURI BHASKAR
Director
—
—
—
11,654
0.0266%
$990.59K
—
Morrison Scott W
Director
—
—
—
7,638
0.0174%
$649.23K
—
Crane Rosemary A
Director
—
—
—
5,350
0.0122%
$454.75K
—
PYOTT DAVID E I
Director
—
—
—
1,383
0.0032%
$117.56K
—

Individual transactions

64
Insider
Date
Role
Action
Shares
Price
Amount
Neervannan Seshadri
4 Sep 2026
Chief Operating Officer
Sold on a plan
4,564
$85.00
$387.94K
Azamian Bobak R.
4 Sep 2026
President/CEO and Board Chair
Sold on a plan indirect
2,900
$91.27
$264.68K
Azamian Bobak R.
4 Sep 2026
President/CEO and Board Chair
Sold on a plan indirect
7,100
$90.27
$640.92K
Lin Elizabeth Yeu
4 Sep 2026
Chief Medical Officer
Sold on a plan indirect
1,590
$90.00
$143.10K
Lin Elizabeth Yeu
4 Sep 2026
Chief Medical Officer
Sold on a plan indirect
1,590
$85.00
$135.15K
Lin Elizabeth Yeu
4 Sep 2026
Chief Medical Officer
Sold on a plan
5,386
$90.00
$484.74K
Lin Elizabeth Yeu
4 Sep 2026
Chief Medical Officer
Sold on a plan
5,387
$85.00
$457.90K
Lin Elizabeth Yeu
2 Sep 2026
Chief Medical Officer
Sold on a plan indirect
1,590
$80.00
$127.20K
Lin Elizabeth Yeu
2 Sep 2026
Chief Medical Officer
Sold on a plan
5,387
$80.00
$430.96K
Azamian Bobak R.
2 Sep 2026
President/CEO and Board Chair
Sold on a plan indirect
10,000
$80.06
$800.60K
Lin Elizabeth Yeu
1 Sep 2026
Chief Medical Officer
Sold on a plan
4,601
$73.86
$339.83K
Azamian Bobak R.
17 Jun 2026
President/CEO and Board Chair
Sold on a plan indirect
5,418
$61.81
$334.89K
Azamian Bobak R.
17 Jun 2026
President/CEO and Board Chair
Sold on a plan indirect
4,582
$61.24
$280.60K
LINK WILLIAM J PHD
15 Jun 2026
Director
Sold on a plan
1,928
$62.94
$121.35K
LINK WILLIAM J PHD
15 Jun 2026
Director
Sold on a plan
10,572
$61.97
$655.15K
Goodrich Katherine
15 Jun 2026
Director
Sold on a plan
2,954
$62.08
$183.38K
Neervannan Seshadri
20 Mar 2026
Chief Operating Officer
Sold on a plan
2,989
$66.75
$199.52K
LINK WILLIAM J PHD
16 Mar 2026
Director
Sold on a plan
493
$69.75
$34.39K
LINK WILLIAM J PHD
16 Mar 2026
Director
Sold on a plan
8,378
$69.03
$578.33K
LINK WILLIAM J PHD
16 Mar 2026
Director
Sold on a plan
3,629
$68.09
$247.10K
Neervannan Seshadri
4 Mar 2026
Chief Operating Officer
Sold on a plan
8,366
$76.67
$641.42K
Whitfield Dianne C.
2 Jan 2026
Chief Human Resources Officer
Sold on a plan
893
$82.93
$74.06K
Whitfield Dianne C.
2 Jan 2026
Chief Human Resources Officer
Sold on a plan
835
$81.90
$68.39K
Whitfield Dianne C.
2 Jan 2026
Chief Human Resources Officer
Sold on a plan
8,122
$80.71
$655.53K
Whitfield Dianne C.
2 Jan 2026
Chief Human Resources Officer
Sold on a plan
5,715
$80.09
$457.71K
Azamian Bobak R.
24 Dec 2025
President/CEO and Board Chair
Sold on a plan indirect
557
$83.54
$46.53K
Azamian Bobak R.
24 Dec 2025
President/CEO and Board Chair
Sold on a plan indirect
5,443
$82.41
$448.56K
Whitfield Dianne C.
16 Dec 2025
Chief Human Resources Officer
Sold on a plan
7,397
$80.10
$592.50K
LINK WILLIAM J PHD
15 Dec 2025
Director
Sold on a plan indirect
4,766
$81.50
$388.43K
LINK WILLIAM J PHD
15 Dec 2025
Director
Sold on a plan indirect
5,680
$80.71
$458.43K
LINK WILLIAM J PHD
15 Dec 2025
Director
Sold on a plan
1,148
$82.39
$94.58K
LINK WILLIAM J PHD
15 Dec 2025
Director
Sold on a plan
6,306
$81.75
$515.52K
LINK WILLIAM J PHD
15 Dec 2025
Director
Sold on a plan
5,046
$80.80
$407.72K
Azamian Bobak R.
24 Sep 2025
President/CEO and Board Chair
Sold on a plan indirect
6,000
$55.37
$332.22K
Azamian Bobak R.
11 Aug 2025
President/CEO and Board Chair
Sold on a plan indirect
6,000
$50.00
$300.00K
Mottiwala Aziz
9 Jun 2025
Chief Commercial Officer
Sold on a plan
17,500
$43.76
$765.80K
Azamian Bobak R.
27 Dec 2023
President/CEO and Board Chair
Sold on a plan indirect
8,000
$20.22
$161.76K
Azamian Bobak R.
20 Dec 2023
President/CEO and Board Chair
Sold on a plan indirect
30,557
$20.36
$622.14K
Azamian Bobak R.
20 Dec 2023
President/CEO and Board Chair
Sold on a plan indirect
9,443
$19.96
$188.48K
Trevejo Jose M.
20 Dec 2023
CHIEF MEDICAL OFFICER
Sold on a plan
2,252
$20.00
$45.04K
Azamian Bobak R.
15 Nov 2023
President/CEO and Board Chair
Sold on a plan indirect
200
$19.28
$3.86K
Azamian Bobak R.
15 Nov 2023
President/CEO and Board Chair
Sold on a plan indirect
4,904
$18.54
$90.92K
Azamian Bobak R.
15 Nov 2023
President/CEO and Board Chair
Sold on a plan indirect
2,896
$18.01
$52.16K
Azamian Bobak R.
18 Oct 2023
President/CEO and Board Chair
Sold on a plan indirect
8,000
$13.24
$105.92K
Trevejo Jose M.
5 Oct 2023
CHIEF MEDICAL OFFICER
Sold on a plan
1,604
$18.00
$28.87K
Azamian Bobak R.
20 Sep 2023
President/CEO and Board Chair
Sold on a plan indirect
8,000
$17.21
$137.68K
Azamian Bobak R.
23 Aug 2023
President/CEO and Board Chair
Sold on a plan indirect
8,000
$17.23
$137.84K
Azamian Bobak R.
19 Jul 2023
President/CEO and Board Chair
Sold on a plan indirect
99,726
$20.04
$2.00M
Azamian Bobak R.
19 Jul 2023
President/CEO and Board Chair
Sold on a plan indirect
4,174
$19.28
$80.47K
Mottiwala Aziz
19 Jul 2023
Chief Commercial Officer
Sold on a plan
2,400
$20.05
$48.12K
Azamian Bobak R.
12 Jul 2023
President/CEO and Board Chair
Sold on a plan indirect
9,000
$17.35
$156.15K
Azamian Bobak R.
21 Jun 2023
President/CEO and Board Chair
Sold on a plan indirect
8,000
$18.63
$149.04K
Azamian Bobak R.
14 Jun 2023
President/CEO and Board Chair
Sold on a plan indirect
9,000
$18.58
$167.22K
Mottiwala Aziz
8 Jun 2023
Chief Commercial Officer
Sold on a plan
100
$20.00
$2.00K
Azamian Bobak R.
8 Jun 2023
President/CEO and Board Chair
Sold on a plan indirect
3,100
$20.01
$62.03K
Mottiwala Aziz
7 Jun 2023
Chief Commercial Officer
Sold on a plan
2,500
$19.34
$48.35K
Mottiwala Aziz
6 Jun 2023
Chief Commercial Officer
Sold on a plan
2,143
$18.61
$39.88K
Azamian Bobak R.
17 May 2023
President/CEO and Board Chair
Sold on a plan indirect
8,000
$15.90
$127.20K
Azamian Bobak R.
10 May 2023
President/CEO and Board Chair
Sold on a plan indirect
9,000
$16.80
$151.20K
Azamian Bobak R.
1 May 2023
President/CEO and Board Chair
Sold on a plan indirect
5,841
$15.10
$88.20K
Azamian Bobak R.
28 Apr 2023
President/CEO and Board Chair
Sold on a plan indirect
4,278
$15.13
$64.73K
Azamian Bobak R.
21 Apr 2023
President/CEO and Board Chair
Sold on a plan indirect
2,311
$15.03
$34.73K
Greenstein Leonard M.
20 Apr 2023
Chief Financial Officer
Sold on a plan
5,000
$14.02
$70.10K
Azamian Bobak R.
19 Apr 2023
President/CEO and Board Chair
Sold on a plan indirect
8,000
$13.60
$108.80K
Showing 250 of 271 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 300
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 64
Sales straight out of an exercise 2
Sales at will 191
Transactions with no price 0
Shares from compensation/vesting 11,492,783
Sales filed before the plan box existed 99
History held since 20 Oct 2020